miraDry® Achieves Remarkable 55% Growth While Launching Odor Awareness Week

miraDry® Reports Significant Growth in Patient Spending

miraDry, Inc., a pioneering company specializing in non-surgical solutions for excessive underarm sweat and odor, has documented a remarkable 55% year-over-year increase in patient spending. The announcement comes as the company embarks on its annual Odor Awareness Week, aiming to shed light on an often stigmatized health topic. This growth not only highlights the demand for miraDry's offerings but also signifies a broader cultural shift in the wellness landscape.

In the first quarter of 2026, miraDry noted a total treatment increase of 43% compared to the same time in the previous year. In contrast, the overall aesthetic energy-based device market, which includes a variety of non-invasive treatments, only registered a modest 4% growth. This compelling data is corroborated by third-party research provider Guidepoint Qsight, which tracks real-time transactions from various aesthetic practices. Their findings suggest that miraDry is not just outperforming its peers; it’s establishing itself as a market leader.

"This surge in both patient spending and treatment volume is indicative of a significant demand shift," explains Kelly Holbin, Head of Consumable Sales, North America at miraDry. Holbin emphasizes this represents a growing awareness that treatments are not only about aesthetics but also about improving patients' overall well-being. Patients now look for solutions that enhance their quality of life, with miraDry at the forefront of delivering such services.

Moreover, the demographics of miraDry's patient base have evolved significantly. The proportion of patients over 35 has increased by 8%, now accounting for nearly half of all miraDry users. This trend points to an emerging need among individuals experiencing perspiration and odor issues during midlife—a subject that remains largely unaddressed despite its prevalence. Notably, approximately 70% of women in perimenopause report a noticeable increase in body odor, yet only 9% discuss this common issue openly, revealing a considerable and overlooked patient population.

"Healthcare providers are increasingly recognizing the potential of miraDry as part of a progressive wellness offering that appeals to a wider patient demographic," adds Larry Lewis, Vice President of Sales, North America at miraDry. Practices incorporating miraDry into their service portfolios are reportedly attracting new patients and sustaining growth.

In line with their mission to elevate awareness around body odor, miraDry has scheduled its Odor Awareness Week starting April 20, 2026. This initiative will include a featured webinar on April 23, led by the renowned 'Dr. Armpit,' Chris Callewaert, who will delve into the science of body odor while addressing emerging patient trends and practical solutions for healthcare providers. This event aligns with the company’s commitment to education and community engagement in addressing an often-ignored health concern.

For those looking to learn more about miraDry’s transformative solutions or to register for the upcoming webinar, further details can be found on their official website www.miradry.com.

As a safe, FDA-cleared procedure, miraDry offers lasting results for excessive underarm sweat, odor, and hair. To date, more than 500,000 patients worldwide have benefited from this innovative treatment, demonstrating its effectiveness and high levels of patient satisfaction. The future looks bright for miraDry as it continues to lead the way in the wellness movement, emphasizing the importance of addressing both the aesthetic and health-related aspects of body odor and sweat management.